From November 12–15, 2026, the 31st Annual Meeting of the Society for Neuro-Oncology (SNO) will bring together more than 3,000 researchers and clinician scientists from around the world in Philadelphia. As one of the leading international forums for neuro-oncology, SNO 2026 will focus on the latest developments in neuro-oncology research and treatment.
Our experts will be attending SNO 2026 and are looking forward to connecting with researchers and clinical trial professionals. Meet us to learn more about how mint Lesion supports imaging-based clinical trials through structured, standardized tumor response assessments, longitudinal lesion tracking, and consistent data collection across time points and study sites.
Meet us at SNO 2026 and discover how mint Lesion can support your clinical trial imaging workflows.